Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
British Journal of Haematology|February 1, 2021
Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species- and GSK3β-dependent mechanismAladin Samara, Saar Shapira, Ido Lubin, et al.Experimental Hematology|November 12, 2018
Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1α expressionSaar Shapira, Pia Raanani, Aladin Samara, et al.Cancer Letters|May 5, 2012
Second-generation tyrosine kinase inhibitors reduce telomerase activity in K562 cellsSaar Shapira, Galit Granot, Rahav Mor-Tzuntz, et al.Hematological Oncology|December 1, 2022
Using natural killer cell-derived exosomes as a cell-free therapy for leukemiaAladin Samara, Michael Anbar, Saar Shapira, et al.Leukemia & Lymphoma|May 10, 2018
Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cellsAyala Gover-Proaktor, Galit Granot, Metsada Pasmanik-Chor, et al.Leukemia & Lymphoma|October 14, 2016
Ponatinib reduces viability, migration, and functionality of human endothelial cellsAyala Gover-Proaktor, Galit Granot, Saar Shapira, et al.International Journal of Molecular Sciences|January 8, 2025
Interferon-α Inhibits NET Formation in Neutrophils Derived from Patients with Myeloproliferative Neoplasms in a Neutrophil Sub-Population-Specific MannerShirly Partouche, Idan Goldberg, Erez Halperin, et al.British Journal of Haematology|June 15, 2024
Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemiaAyala Gover-Proaktor, Dorit Leshem-Lev, Sabina Winograd-Katz, et al.Pageof 1